Disopyramide Phosphate (Mayne Pharma Inc.)


Welcome to the PulseAid listing for the Disopyramide Phosphate drug offered from Mayne Pharma Inc.. This Antiarrhythmic [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Mayne Pharma Inc.
NON-PROPRIETARY NAME: Disopyramide Phosphate
SUBSTANCE NAME: DISOPYRAMIDE PHOSPHATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Antiarrhythmic [EPC]
ROUTE: ORAL
DOSAGE FORM: CAPSULE
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2016-08-03
END MARKETING DATE: 0000-00-00


Disopyramide Phosphate HUMAN PRESCRIPTION DRUG Details:

Item DescriptionDisopyramide Phosphate from Mayne Pharma Inc.
LABELER NAME: Mayne Pharma Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 100(mg/1)
START MARKETING DATE: 2016-08-03
END MARKETING DATE: 0000-00-00
PRODUCT ID: 51862-093_ff6d73b5-1e4e-48bc-bee1-40a312f19c98
PRODUCT NDC: 51862-093
APPLICATION NUMBER: ANDA070173

Other DISOPYRAMIDE PHOSPHATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Actavis Pharma, Inc.Disopyramide Phosphate
AvKARE, Inc.Disopyramide Phosphate
Carilion Materials ManagementNorpace
G.D. Searle LLC Division of Pfizer IncNorpace CR
Mayne Pharma Inc.Disopyramide Phosphate
Teva Pharmaceuticals USA IncDisopyramide Phosphate